NASDAQ:CDMO

Avid Bioservices, Inc Earning Date

USA |NASDAQ |USD

CDMO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 30, 2021 Oct 2021 $0.02 $0.13 $0.01
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 30, 2021 Oct 2021 $24.02M $30.75M $21.06M

Avid Bioservices, Inc's next earnings date is Tuesday, Nov 30, 2021 for the fiscal quarter ending Oct 2021.

CDMO Earnings Date & History Chart

CDMO Earnings & Revenue Forecast

CDMO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Oct 2021 4 $0.02 $0.01 $0.04
Jan 2022 4 $0.03 $0.00 $0.04
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Apr 2022 4 $0.23 $0.20 $0.26
Apr 2023 4 $0.34 $0.29 $0.42

CDMO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Oct 2021 0 / 0 $0.03 $0.02 $0.02
Jan 2022 0 / 0 $0.03 $0.03 $0.03
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Apr 2022 0 / 0 $0.23 $0.21 $0.21
Apr 2023 0 / 0 $0.34 $0.34 $0.34

CDMO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Oct 2021 4 $24.02M $21.23M $25.19M
Jan 2022 4 $25.11M $21.35M $28.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Apr 2022 4 $116.44M $115.97M $116.95M
Apr 2023 4 $155.66M $146.08M $165.59M

CDMO Earnings Date & Revenue History

CDMO Earnings History

|
Show More
Show More

CDMO Revenue History

|
Show More
Show More

Avid Bioservices, Inc Next Earnings Date & Report

CDMO Next Earnings Date & Report Preview: Oct 2021 (FQ)

CDMO's next earnings date is Tuesday, Nov 30, 2021 for the fiscal quarter ending Oct 31, 2021.

According to 4 analysts, the average EPS estimation for Avid Bioservices, Inc's next quarterly earnings is $0.02, with a low EPS estimation of $0.01, and a high estimation of $0.04.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.03, the last 2 month trend is $0.02, and the 3 month trend is $0.02.

Based on 4 analysts, the average revenue estimation is $24.02M, with a low revenue estimation of $21.23M, and a high estimation of $25.19M.

Avid Bioservices, Inc Previous Earnings Dates & Reports

CDMO Previous Earnings Date & Report Recap: Jul 2021 (FQ)

Avid Bioservices, Inc's previous earnings date was Sep 8, 2021 for its fiscal quarter ended Jul 31, 2021.

CDMO's earnings per share (EPS) was $0.13, beating the consensus analysts forecast of $0.04 by 249.87%.

The EPS was higher than the previous fiscal quarter (Apr 2021) by 1212.00%, and higher than the same period a year before (Jul 2020) by 118.67%.

Revenues were $30.75M, better than the forecast of $27.81M by 10.59%, up by 11.40% from the previous quarter , and up by 21.12% from the same period last year.

The company reported a net income of $6.30M, 216.62% higher than the previous quarter, and higher by 33.28% than the same period a year before.

Free cash flow for the quarter was $-11.14M , compared to $13.71M last quarter and $-2.76M a year before.

CDMO ended the quarter with $164.28M in total debt, an increase of 38.99% compared to the previous quarter, and an increase of 640.69% compared to the same quarter a year before.

CDMO Previous Earnings Date & Report Recap: Apr 2021 (FY)

Avid Bioservices, Inc's previous annual earnings date was Jun 29, 2021 for its fiscal year ended Apr 30, 2021.

CDMO's earnings per share (EPS) was $0.09, beating the consensus analysts forecast of $0.09 by 0.00% , and higher than the previous year's EPS (Apr 2020) by -132.59%.

Revenues were $95.87M, better than the forecast of $89.87M by 6.67%, and up by 60.58% from previous year's revenue.

The company reported a net income of $11.21M.

Avid Bioservices, Inc reported a free cash flow of $21.32M for its fiscal year, compared to $2.02M a year ago.

The company ended the fiscal year with $118.19M in total debt, an increase of 340.18% compared to the previous year.